Wai Conrad 4
4 · CLOVER HEALTH INVESTMENTS, CORP. /DE · Filed Apr 3, 2026
Research Summary
AI-generated summary of this filing
Clover Health (CLOV) CEO Wai Conrad Receives 267,766-Share RSU Award
What Happened
Wai Conrad, CEO (Counterpart Health), was granted a time‑based restricted stock unit (RSU) award for 267,766 shares of Clover Health Class A common stock on April 1, 2026. The Form 4 reports the acquisition price as $0.00 (award/grant), so the reported acquisition value is $0. This is a compensation award rather than an open‑market purchase or sale.
Key Details
- Transaction date: 2026-04-01; Form 4 filed: 2026-04-03 (appears timely).
- Transaction type/code: Award/Grant (A). Price reported: $0.00. Total shares granted: 267,766.
- Shares owned after transaction: not specified in the filing.
- Footnote F1: These are time‑based RSUs — 25% vest on Apr 1, 2027, then the remainder vests in 12 equal quarterly installments beginning three months after that date; fully vested on Apr 1, 2030, subject to continued service.
- Footnote F2: Some shares are held in a family trust for which the reporting person is a co‑trustee.
Context
RSU grants are typical executive compensation and do not represent an immediate market purchase or sale. These RSUs convert to actual shares only as they vest (subject to service conditions) and may have tax consequences upon vesting; they do not by themselves indicate buying or selling sentiment.
Insider Transaction Report
- Award
Class A Common Stock
[F1]2026-04-01+267,766→ 1,193,377 total
- 1,610,482(indirect: By Trust)
Class A Common Stock
[F2]
Footnotes (2)
- [F1]1. Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). Twenty-five percent of the RSUs will vest on the first anniversary of April 1, 2026, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of April 1, 2026, in each case subject to the continued service of the Reporting Person on each such vesting date, so that such RSUs will be fully vested on April 1, 2030.
- [F2]Shares held in trust for the benefit of the Reporting Person's family, of which the Reporting Person is a co-trustee.